Document is current

Any future updates will be listed below

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

Crossref DOI link: https://doi.org/10.1038/s41598-025-01206-9

Published Online: 2025-05-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark